The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nitrofurantoin 100 mg Capsules, hard

Azure Pharmaceuticals LtdPA22871/024/002

Main Information

Trade NameNitrofurantoin 100 mg Capsules, hard
Active SubstancesNitrofurantoin
Dosage FormCapsule, hard
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/024/002

Group Information

ATC CodeJ01XE01 nitrofurantoin


License statusAuthorised
Licence Issued03/09/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back